PLC News

Plc Market news covers the latest developments on the Alternative Investment Market, the London Stock Exchange’s venue for smaller, growth‑orientated companies. This section includes updates on company admissions and delisting’s, fund‑raisings and IPOs, share‑price movements, mergers and acquisitions, board appointments and departures, regulatory and policy changes

Alliance Pharma reports mixed FY2024 results

Alliance Pharma plc (LON: APH) reports a 1% drop in FY 2024 revenues, but with strong gains in Kelo-Cote, MacuShield, and Hydromol segments...

Quadrise raises £6.53 million via Placing, the Subscription and Retail Offer

Quadrise Plc (LON:QED) reports a significantly oversubscribed £2 million Retail Offer, part of a larger £6.53 million fundraising effort for clean energy solutions...

Nuformix advances NXP002 programme with £168,750 Placing

Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...

Poolbeg Pharma granted extension to PUSU Deadline

HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...

Strix Group reports FY24 profits ahead of market consensus

Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...

Union Jack Oil plc Positive update on Moccasin 1-13 Well, Oklahoma

Union Jack Oil plc (LON:UJO, OTCQB: UJOGF) reports promising developments at its Moccasin 1-13 well in Oklahoma, highlighting potential oil prospects...

Hardide plc Annual results FY September 2024, well placed for growth, cash generation and value creation

Hardide plc reports FY24 results, showcasing revenue growth, improved profitability, and strategic advancements in aerospace and industrial sectors...

REACT Group plc Final results show increased revenues, growth and profit

REACT Group Plc (LON:REAT) reports strong financial growth for 2024, driven by a 6% revenue boost to £20.7m and enhanced profitability through strategic initiatives...

Nuformix plc Annual Results for the period ended 30 September 2024

Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...

hVIVO plc Acquires two Clinical Research Units from CRS for €10.0m

hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...

Versarien raises £246,038 via Placing

Versarien plc (LON:VRS) raises £246,038 through a placement of 745 million new shares, enhancing corporate funding and shareholder transparency...

Nuformix submits NXP002 Orphan Drug Designation Application to EMA

Nuformix plc (LON:NFX) advances NXP002 for Idiopathic Pulmonary Fibrosis, applying for Orphan Drug Designation with European Medicines Agency...

Aptamer Group reports on significant commercial and technical progress in H1 report

Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...

Quadrise appoints marine expert Tony Foster as Non-Executive Director

Quadrise Plc (LON: QED) welcomes Tony Foster as Non-Executive Director, enhancing their maritime and decarbonisation expertise from February 2025...

Time Finance reports record lending book, fourteen consecutive quarters of growth

Time Finance plc's interim results show impressive growth, with a 16% revenue increase and a 44% rise in profit. Explore their strategic updates...

Diversified Energy expands asset base with Maverick Natural Resources acquisition

Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...

Tekmar Group awarded £5 million offshore wind farm contract

Tekmar Group secures a £5M contract for a UK offshore wind project, highlighting its leading cable protection system and engineering expertise...

hVIVO selected to conduct large-scale phase 3 Whooping Cough trial

hVIVO partners with ILiAD Biotechnologies for the first-ever Phase 3 human challenge trial of BPZE1, a next-gen Bordetella pertussis vaccine...

Amaroq Minerals publishes new episode of its South Greenland documentary series

Discover Amaroq Minerals' latest documentary episode on their journey to first gold pour at Nalunaq mine, exploring Greenland's rich mineral potential...

Cohort Plc CEO Andrew Thomis to present Zoom Webinar

Cohort plc (LON:CHRT) to present its half-year results and corporate strategy at MelloMonday via Zoom on January 27, 2025. Register for free today!..
Search

Funds

Interviews

Alliance Pharma reports mixed FY2024 results

Alliance Pharma plc (LON: APH) reports a 1% drop in FY 2024 revenues, but with strong gains in Kelo-Cote, MacuShield, and Hydromol segments...

Quadrise raises £6.53 million via Placing, the Subscription and Retail Offer

Quadrise Plc (LON:QED) reports a significantly oversubscribed £2 million Retail Offer, part of a larger £6.53 million fundraising effort for clean energy solutions...

Nuformix advances NXP002 programme with £168,750 Placing

Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...

Poolbeg Pharma granted extension to PUSU Deadline

HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...

Strix Group reports FY24 profits ahead of market consensus

Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...

Union Jack Oil plc Positive update on Moccasin 1-13 Well, Oklahoma

Union Jack Oil plc (LON:UJO, OTCQB: UJOGF) reports promising developments at its Moccasin 1-13 well in Oklahoma, highlighting potential oil prospects...

Hardide plc Annual results FY September 2024, well placed for growth, cash generation and value creation

Hardide plc reports FY24 results, showcasing revenue growth, improved profitability, and strategic advancements in aerospace and industrial sectors...

REACT Group plc Final results show increased revenues, growth and profit

REACT Group Plc (LON:REAT) reports strong financial growth for 2024, driven by a 6% revenue boost to £20.7m and enhanced profitability through strategic initiatives...

Nuformix plc Annual Results for the period ended 30 September 2024

Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...

hVIVO plc Acquires two Clinical Research Units from CRS for €10.0m

hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...

Versarien raises £246,038 via Placing

Versarien plc (LON:VRS) raises £246,038 through a placement of 745 million new shares, enhancing corporate funding and shareholder transparency...

Nuformix submits NXP002 Orphan Drug Designation Application to EMA

Nuformix plc (LON:NFX) advances NXP002 for Idiopathic Pulmonary Fibrosis, applying for Orphan Drug Designation with European Medicines Agency...

Aptamer Group reports on significant commercial and technical progress in H1 report

Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...

Quadrise appoints marine expert Tony Foster as Non-Executive Director

Quadrise Plc (LON: QED) welcomes Tony Foster as Non-Executive Director, enhancing their maritime and decarbonisation expertise from February 2025...

Time Finance reports record lending book, fourteen consecutive quarters of growth

Time Finance plc's interim results show impressive growth, with a 16% revenue increase and a 44% rise in profit. Explore their strategic updates...

Diversified Energy expands asset base with Maverick Natural Resources acquisition

Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...

Tekmar Group awarded £5 million offshore wind farm contract

Tekmar Group secures a £5M contract for a UK offshore wind project, highlighting its leading cable protection system and engineering expertise...

hVIVO selected to conduct large-scale phase 3 Whooping Cough trial

hVIVO partners with ILiAD Biotechnologies for the first-ever Phase 3 human challenge trial of BPZE1, a next-gen Bordetella pertussis vaccine...

Amaroq Minerals publishes new episode of its South Greenland documentary series

Discover Amaroq Minerals' latest documentary episode on their journey to first gold pour at Nalunaq mine, exploring Greenland's rich mineral potential...

Cohort Plc CEO Andrew Thomis to present Zoom Webinar

Cohort plc (LON:CHRT) to present its half-year results and corporate strategy at MelloMonday via Zoom on January 27, 2025. Register for free today!..
Search

Funds

PLC News

FTSE 100

Funds